An Open-label, Multi-centre, Long-term Extension Study of Zanubrutinib (BGB-3111) in patients with B-cell Malignancies (BGB-3111-LTE1) (NCT04170283)
BGB-3111-LTE1
This trial is No longer recruiting
Registration number NCT04170283
Program & service
This trial is being run with the Cancer service, and as part of the Haematology program.
Trial phase
Phase 3
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Dr Sushrut Patil
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR